Prothena | Fremdkapital





Fremdkapital Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Akebia Therapeutics USD 47.64M 579K 2025-09
ALKERMES USD 285.82M 639K 2024-09
Alnylam Pharmaceuticals USD 1.04B 13.75M 2025-09
Amgen USD 50B 2.43B 2025-12
Biogen USD 6.29B 1.4M 2025-09
BioMarin Pharmaceutical USD 596.66M 501K 2025-09
Immunic USD 0 0 2024-06
Incyte USD 35.37M 3.61M 2025-09
Ionis Pharmaceuticals USD 28.78M 596.71M 2025-09
MacroGenics USD 70.26M 4K 2025-09
Nektar Therapeutics USD 107.51M 10.35M 2024-06
Neurocrine Biosciences USD 169.5M 500K 2023-03
Prothena USD 0 0 2024-12
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Ultragenyx Pharmaceutical USD 782.75M 11.3M 2025-06
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03
Xoma USD 94.38M 7.82M 2025-09


Prothena Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.